Skip to main content
. 2022 Mar 24;42(3):334–339. doi: 10.1097/WNO.0000000000001560

TABLE 1.

Key criteria for expert participation

Oculoplastic surgeon, ophthalmologist, or neuro-ophthalmologist
Working in their chosen medical specialty for ≥24 mo
Personally responsible for the management of patients with TED
Personally prescribed teprotumumab to at least 3 patients
Actively treating patients with TED

TED, thyroid eye disease.